Eleonora Restuccia
- Oncology top 5%
- HER2/EGFR in Cancer Research 38
- Cancer Treatment and Pharmacology 17
- Peptidase Inhibition and Analysis 8
- Colorectal Cancer Treatments and Studies 3
-
- Breast Cancer Treatment Studies 22
-
- Monoclonal and Polyclonal Antibodies Research 13
-
- Advanced Breast Cancer Therapies 13
- Gastric Cancer Management and Outcomes 4
- Co-authors
- Sarah HeesonThierry PetitMichael AnderssonClaudio ZamagniJosé Manuel López-VegaEdith A. PerezValerie EastonDaniel Eiger
- Journals
- Journal of Clinical Oncology (8 papers)JNCI Journal of the National Cancer Institute (2 papers)Cancer Research (9 papers)
- Partner nations
- SwitzerlandUnited KingdomUnited States
In The Last Decade
Eleonora Restuccia
44 papers receiving 614 citations
Peers
Comparison fields: 5 of 54
- Oncology 524
- Cancer Research 154
- Radiology, Nuclear Medicine and Imaging 207
- Pulmonary and Respiratory Medicine 212
- Immunology 78
Countries citing papers authored by Eleonora Restuccia
This map shows the geographic impact of Eleonora Restuccia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eleonora Restuccia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eleonora Restuccia more than expected).
Fields of papers citing papers by Eleonora Restuccia
This network shows the impact of papers produced by Eleonora Restuccia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eleonora Restuccia. The network helps show where Eleonora Restuccia may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eleonora Restuccia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 2 | |
| 6 | 2022 | 82 | |
| 7 | 2022 | 15 | |
| 8 | 2022 | 8 | |
| 9 | 2022 | 15 | |
| 10 | 2022 | 11 | |
| 11 | 2022 | 4 | |
| 12 | 2021 | 3 | |
| 13 | 2021 | 5 | |
| 14 | 2021 | 4 | |
| 15 | 2021 | 23 | |
| 16 | 2020 | 29 | |
| 17 | 2020 | 9 | |
| 18 | 2020 | 104 | |
| 19 | 2019 | 4 | |
| 20 | 2013 | 11 |
About Eleonora Restuccia
Eleonora Restuccia is a scholar working on Oncology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 48 papers that have together received 626 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (38 papers), Breast Cancer Treatment Studies (22 papers), Cancer Treatment and Pharmacology (17 papers), Advanced Breast Cancer Therapies (13 papers), Monoclonal and Polyclonal Antibodies Research (13 papers), Peptidase Inhibition and Analysis (8 papers), Gastric Cancer Management and Outcomes (4 papers) and Colorectal Cancer Treatments and Studies (3 papers). The work is most often cited by research in Oncology (524 citations), Cancer Research (154 citations) and Radiology, Nuclear Medicine and Imaging (207 citations). Eleonora Restuccia has collaborated with scholars based in Switzerland, United Kingdom and United States. Frequent co-authors include Sarah Heeson, Thierry Petit, Michael Andersson, Claudio Zamagni, José Manuel López-Vega, Edith A. Perez, Valerie Easton, Daniel Eiger, Chiara Lambertini and Zbigniew Nowecki. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.